| name | endo-vitd-no-screening-dark-complexion |
| description | The guideline recommends against routine 25(OH)D screening and subsequent vitamin D treatment in adults with dark complexion who lack established indications for testing. Consider this recommendation when clinicians ask, "Should I screen for vitamin D deficiency in this patient with dark skin?" or "Is vitamin D testing indicated based on skin complexion?" |
Against routine vitamin D screening in dark complexion adults
STEP 1 — Gather Information
Collect patient age, observed or self-reported dark complexion (e.g., Fitzpatrick V-VI), presence of established indications for 25(OH)D testing (hypocalcemia, malabsorption, chronic kidney disease, etc.), and pregnancy status.
Action: If the patient is an adult with dark complexion and lacks established indications for testing, proceed to Step 2.
STEP 2 — Rule In / Rule Out
If any established indication for 25(OH)D testing is present (e.g., hypocalcemia, malabsorption, renal osteodystrophy), rule in: proceed to targeted testing per standard of care (outside this guideline). Otherwise, rule out routine screening and proceed to Step 3.
STEP 3 — Classify or Stratify
Classify the patient as a candidate for empiric vitamin D supplementation only if they belong to a group with a guideline recommendation for empiric supplementation (age 1‑18 years, ≥75 years, pregnancy, or high‑risk prediabetes); otherwise classify as not indicated for empiric supplementation.
Action: If classified as a candidate for empiric supplementation, proceed to Step 4A; if not, proceed to Step 4B.
STEP 4 — Decide
4A: For candidates for empiric supplementation, initiate age‑appropriate empiric vitamin D dosing (per guideline) without prior 25(OH)D testing.
4B: For those not meeting empiric supplementation criteria, do not order 25(OH)D testing and do not initiate empiric vitamin D supplementation; advise on dietary sources and safe sun exposure as needed.
Clinical Guardrails / Mimics / Pitfalls
Do not use race as a proxy for dark complexion; assess skin pigmentation directly. Do not extrapolate to patients with conditions that alter vitamin D metabolism (e.g., malabsorption, renal disease). Do not order 25(OH)D testing based solely on skin complexion. Do not initiate high‑dose intermittent vitamin D without a specific indication. Do not assume low 25(OH)D levels based on complexion alone.
Concrete Clinical Example
A 55‑year‑old African American woman with Fitzpatrick skin type VI presents for a routine preventive visit. She denies symptoms of hypocalcemia, malabsorption, or bone pain and asks whether she should be checked for vitamin D deficiency. Following the guideline, we advise against routine 25(OH)D screening; we note that empiric supplementation is not recommended for her age group without other indications, and we counsel on dietary vitamin D sources and safe sun exposure.
Source: Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2024, https://doi.org/10.1210/clinem/dgae290
